IQVIA Holdings Inc. (iqv)
IQV — Company Overview
IQVIA Holdings Inc. (IQV) trades on NYQ as part of the Healthcare peer group (Diagnostics & Research).
| Ticker | IQV |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Exchange | NYQ |
| Market cap | $44.09B |
| Last price | $267.86 |
| Size category | Large Cap |
IQV — Business Description
IQV represents a Diagnostics & Research business in the Healthcare segment. IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, su…
Official website: https://www.iqvia.com.
IQV — Investment Thesis
At a high level, IQV offers exposure to Healthcare with metrics outlined below from public market data.
- Revenue is expanding at roughly 8.7% year-over-year (public data).
- Trailing P/E of 33.57× sits in a moderate band relative to high-growth peers.
- Forward P/E (18.52×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $44.09B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
IQV — Financial Health
Key financial health indicators for IQVIA Holdings Inc. are derived exclusively from public data — no proprietary estimates.
Profit margin near 8.1% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $2.15B supports balance-sheet flexibility. Debt-to-equity of 257.98 warrants monitoring in a higher-rate environment.
| Trailing P/E | 33.57× |
| Forward P/E | 18.52× |
| Price / Sales | 2.60× |
| Price / Book | 7.14× |
| Gross margin | 33.0% |
| Operating margin | 13.0% |
| Profit margin | 8.1% |
| Return on equity | 22.8% |
| Debt / Equity | 257.98 |
| Free cash flow | $2.15B |
IQV — Growth Outlook
Growth outlook for IQVIA Holdings Inc. (IQV) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 8.7% suggests steady but measured expansion.
- Earnings declined -0.6% year-over-year — margin or volume pressure may be in play.
- Price is 3.4% below the 52-week high.
IQV — Competitive Position
IQVIA Holdings Inc. (IQV) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Diagnostics & Research.
- Market capitalization of $44.09B places IQV among large-cap peers.
- Gross margin of 33.0% should be benchmarked against direct competitors.
IQV — Strengths
Strengths for IQVIA Holdings Inc. (IQV) inferred from public financial metrics:
- Revenue growth of 8.7% year-over-year.
- Return on equity near 22.8% — efficient use of shareholder capital.
- Positive free cash flow ($2.15B).
- Large Cap scale ($44.09B) may provide distribution and funding advantages.
- Price near 52-week highs — positive price momentum on public markets.
IQV — Weaknesses
Weaknesses and pressure points for IQVIA Holdings Inc. (IQV) based on available data:
- Earnings decline of -0.6% year-over-year.
- Elevated debt-to-equity (257.98).
IQV — Opportunities
- Sustained revenue growth (8.7%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
IQV — Risks
- Leverage (debt/equity 257.98) raises sensitivity to credit conditions.
IQV — Summary
IQVIA Holdings Inc. (IQV) is a large-cap Healthcare company focused on Diagnostics & Research, listed on NYQ. Last price $267.86 with market cap $44.09B. Trailing P/E 33.57×. Revenue grew 8.7% year-over-year per public data. Notable strengths include revenue growth of 8.7% year-over-year. Key watch items include earnings decline of -0.6% year-over-year. Premium Terminal tools for IQVIA Holdings Inc. add ownership analytics, news, and richer estimate history beyond this public summary.
Start Free — open IQV in Vest Terminal
Access live data, filings, ownership, and analysis for IQVIA Holdings Inc..
IQVIA Holdings Inc. FAQ
What does IQVIA Holdings Inc. (IQV) do?
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, R…
What is IQV's P/E ratio?
IQVIA Holdings Inc. has a trailing P/E of 33.57× based on publicly available market data.
Does IQV pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is IQV in?
IQVIA Holdings Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is IQV's market capitalization?
Approximate market cap: $44.09B.
What are the main risks for IQV?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of IQV?
Potential positives include revenue growth of 8.7% year-over-year, return on equity near 22.8% — efficient use of shareholder capital.
Where can I get analyst estimates for IQV?
Public analyst price targets and consensus for IQVIA Holdings Inc. are on the free /stocks/iqv/estimates page. Deeper estimate history and models are available in Vest Terminal.